Effect of tezepelumab on exacerbation-related intravenous corticosteroid use in patients with severe, uncontrolled asthma in NAVIGATOR
A. Bourdin (Montpellier , France), N. Martin (Leicester, United Kingdom), C. Ambrose (Gaithersburg, United States), S. Ponnarambil (Cambridge, United Kingdom), G. Hunter (Cambridge, United Kingdom), N. Molfino (California, United States), B. Cook (Gaithersburg, United States)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4313
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bourdin (Montpellier , France), N. Martin (Leicester, United Kingdom), C. Ambrose (Gaithersburg, United States), S. Ponnarambil (Cambridge, United Kingdom), G. Hunter (Cambridge, United Kingdom), N. Molfino (California, United States), B. Cook (Gaithersburg, United States). Effect of tezepelumab on exacerbation-related intravenous corticosteroid use in patients with severe, uncontrolled asthma in NAVIGATOR. 4313
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|